跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,035 条关于
“Guangzhou-Israel Biotechnology Fund”
全部
8,035
临床试验
548
药物
899
机构
448
资讯
6,140
2年前
BioVersys Secures $6M Investment to Advance BV100 Clinical Program in China
3个月前
Biond Biologics Secures $8M Investment from GIBF to Advance Novel Immunotherapies in China
去年
Guangzhou Baiyunshan Receives Approval for Generic Drug
10个月前
Forbion Closes €200 Million BioEconomy Fund to Drive Sustainable Biotechnology Innovation
去年
HKUST and SIIC Launch HK$600 Million Biotechnology Fund to Accelerate Healthcare Innovation
去年
MAIA Biotechnology Raises $695,000 in Private Placement to Fund Phase II THIO-101 Cancer Trial
3个月前
Kos Biotechnology Partners Closes $123 Million Inaugural Life Sciences Fund, Marking Greece's Largest VC Launch
去年
Israel Unveils Streamlined Drug Approval Process to Accelerate Patient Access
5年前
Prestige Biopharma Partners with Teva Israel for Trastuzumab Biosimilar Commercialization
7个月前
Scinai Immunotherapeutics Completes Acquisition of Recipharm Israel and Forms Strategic CDMO Partnership
第 1 页，共 614 页
上一页
下一页
